Latest bladder cancer Stories
Indian researchers say a simple urine test could offer a less invasive diagnostic solution for early stage bladder cancer. Raleigh, NC (PRWEB) March 14, 2014
A new study published in the British Journal of Clinical Pharmacology, recommends prescribers limit pioglitazone (Actos) use to shorter durations due to significantly increased risk of bladder
Another meta-analysis has confirmed an increased risk of bladder cancer among diabetes patients who have taken the drug Actos (pioglitazone). Raleigh, NC (PRWEB)
National network of attorneys continues to provide no-cost consultations over allegations that the use of the diabetes medication Actos can cause bladder cancer. San
Diabetic patients who develop bladder cancer after taking the drug Actos (pioglitazone) tend to have about the same number of Stage I, II, and III cancers as surgical patients who never used Actos.
Research on more than 11,000 Korean users of the diabetes drug pioglitazone finds that smaller doses are no protection against bladder cancer. Raleigh, NC (PRWEB)
A new study says patients with diabetes are more likely to be readmitted to the hospital after bladder cancer surgery. Raleigh, NC (PRWEB) February 23, 2014
Taiwanese author says his research should relieve concern among diabetics that insulin might raise their cancer risk. Raleigh, NC (PRWEB) February 19, 2014
University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
Scientists find a “modest but clinically significant” link between the diabetes drug and bladder cancer. Raleigh, NC (PRWEB) February 17, 2014 The
- Emitting flashes of light; glittering.